Please assess the completion status of the following clinical trial:

Trial Title: Dienogest for Treatment of Adenomyotic Uteri

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women aged 20-40 years~* Women with ultrasonographic evidence of adenomyosis~* Woman complains of vaginal bleeding or pelvic pain related to adenomyosis~Exclusion Criteria:~* Women with a history of malignancy or histological evidence of endometrial hyperplasia~* any adnexal abnormality on ultrasound~* undiagnosed vaginal~* contraindication to receive Vissane or gynera .

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Dienogest group (Type: ACTIVE_COMPARATOR): None
- Gynera group (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).